New antibody-drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies ...
Researchers developed monoclonal antibody mAb122 to target pyocyanin, a key toxin of Pseudomonas aeruginosa. In cell studies, ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...
The lack of high-resolution structures of the hantavirus glycoprotein tetramer and its lattice organization has limited mechanistic insights into viral assembly and entry. The authors leveraged a ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was publi ...
Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single ...
Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a virus believed to infect about 95% of people worldwide. EBV has been linked ...